Stay updated with breaking news from Genscript Biotech Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genscript Biotech Co. (OTCMKTS:GNNSF – Get Rating) saw a large increase in short interest in April. As of April 30th, there was short interest totalling 5,524,500 shares, an increase of 31.8% from the April 15th total of 4,192,500 shares. Based on an average daily volume of 2,900 shares, the days-to-cover ratio is currently 1,905.0 days. […]
Genscript Biotech Co. (OTCMKTS:GNNSF – Get Rating) was the target of a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 5,524,500 shares, a growth of 31.8% from the April 15th total of 4,192,500 shares. Based on an average daily trading volume, of 2,900 shares, […]
Genscript Biotech Co. (OTCMKTS:GNNSF – Get Rating) saw a significant drop in short interest in March. As of March 31st, there was short interest totalling 364,100 shares, a drop of 60.5% from the March 15th total of 922,500 shares. Based on an average daily volume of 4,400 shares, the days-to-cover ratio is presently 82.8 days. […]
Genscript Biotech Co. (OTCMKTS:GNNSF – Get Rating)’s stock price dropped 12.2% during trading on Thursday . The stock traded as low as 3.06 and last traded at 3.06. Approximately 2,000 shares traded hands during mid-day trading, a decline of 14% from the average daily volume of 2,338 shares. The stock had previously closed at 3.49. […]